<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.pharmtech.com/view/gene-therapy-developers-face-new-postmarket-fda-safety-council</loc>
      <lastmod>2026-11-20T14:43:26.636Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Technology</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-20T14:43:26.636Z</news:publication_date>
        <news:title><![CDATA[Gene Therapy Developers Face New Postmarket FDA Safety Council]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/ai-pulse-check-annex-22-favors-static-models</loc>
      <lastmod>2026-11-19T17:30:42.846Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Technology</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T17:30:42.846Z</news:publication_date>
        <news:title><![CDATA[AI Pulse Check: Annex 22 Favors Static Models]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/our-2026-workforce-survey-is-open</loc>
      <lastmod>2026-11-19T16:56:18.477Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Technology</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T16:56:18.477Z</news:publication_date>
        <news:title><![CDATA[Our 2026 Workforce Survey Is Open]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/what-venglustat-s-approval-means-for-rare-disease-developers</loc>
      <lastmod>2026-11-19T15:50:06.985Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Technology</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T15:50:06.985Z</news:publication_date>
        <news:title><![CDATA[What Venglustat’s Approval Means for Rare Disease Developers]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/breaking-the-biomanufacturing-mold-a-patient-centric-approach</loc>
      <lastmod>2026-11-19T15:09:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Technology</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T15:09:00Z</news:publication_date>
        <news:title><![CDATA[Breaking the Biomanufacturing Mold: A Patient Centric Approach]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/are-your-supplier-selection-and-oversight-processes-robust-enough-</loc>
      <lastmod>2026-11-19T13:00:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Technology</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-19T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Are Your Supplier Selection and Oversight Processes Robust Enough?]]></news:title>
      </news:news>
	</url><url>
      <loc>https://www.pharmtech.com/view/hpmc-capsule-offers-simpler-formulation</loc>
      <lastmod>2026-11-18T20:55:00Z</lastmod>
      <news:news>
      <news:publication>
        <news:name>Pharmaceutical Technology</news:name>
        <news:language>en</news:language>
      </news:publication>
        <news:publication_date>2026-11-18T20:55:00Z</news:publication_date>
        <news:title><![CDATA[HPMC Capsule Offers Simpler Formulation]]></news:title>
      </news:news>
	</url></urlset>